Anette Pietrzak-Nguyen

MPLA-coated hepatitis B virus surface antigen (HBsAg) nanocapsules induce vigorous T cell responses in cord blood derived human T cells.

K. Landfester, F. Wurm, S. Gehring, 2016, Nanomedicine : nanotechnology, biology, and medicine.

Nanocapsules generated out of a polymeric dexamethasone shell suppress the inflammatory response of liver macrophages.

K. Landfester, G. Baier, S. Gehring, 2013, Nanomedicine : nanotechnology, biology, and medicine.

Monophosphoryl lipid A coating of hydroxyethyl starch nanocapsules drastically increases uptake and maturation by dendritic cells while minimizing the adjuvant dosage.

K. Landfester, S. Strand, G. Baier, 2015, Vaccine.

Enhanced in vivo targeting of murine nonparenchymal liver cells with monophosphoryl lipid A functionalized microcapsules.

K. Landfester, M. Diken, G. Baier, 2014, Biomacromolecules.

Novel strategies in vaccine design: can nanocapsules help prevent and treat hepatitis B?

K. Landfester, S. Gehring, M. Fichter, 2017, Nanomedicine.

Polymeric hepatitis C virus non-structural protein 5A nanocapsules induce intrahepatic antigen-specific immune responses.

K. Landfester, S. Strand, V. Mailänder, 2016, Biomaterials.

MPLA-coated hepatitis B virus surface antigen (HBsAg) nanocapsules induce vigorous T cell responses in cord blood derived human T cells.

K. Landfester, F. Wurm, S. Gehring, 2016, Nanomedicine : nanotechnology, biology, and medicine.

Novel strategies in vaccine design: can nanocapsules help prevent and treat hepatitis B?

K. Landfester, S. Gehring, M. Fichter, 2017, Nanomedicine.